A clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases.
- Year invested 2017
- Investment Stage Public/PIPES
- Sectors
- Investment Status Current
- Associated Team
- Website veronapharma.com
- Company Status IPO/Public (NASDAQ: VRNA)